These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 7620700

  • 1. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R, Renzetti AR, Cucchi P, Guelfi M, Salimbeni A, Caliari S, Castellucci A, Evangelista S, Subissi A, Giachetti A.
    Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M.
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [Abstract] [Full Text] [Related]

  • 5. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    Polidori C, Ciccocioppo R, Pompei P, Cirillo R, Massi M.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):223-8. PubMed ID: 7493612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC, Hart SD, Chiu AT, Herblin WF, Carini DJ, Smith RD, Wexler RR, Timmermans PB.
    J Pharmacol Exp Ther; 1991 Nov 24; 259(2):861-70. PubMed ID: 1941632
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
    Cazaubon C, Gougat J, Bousquet F, Guiraudou P, Gayraud R, Lacour C, Roccon A, Galindo G, Barthelemy G, Gautret B.
    J Pharmacol Exp Ther; 1993 May 24; 265(2):826-34. PubMed ID: 8496828
    [Abstract] [Full Text] [Related]

  • 10. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH, Jung YS, Lee BH, Yun SI, Yoo SE, Shin HS.
    J Cardiovasc Pharmacol; 1999 Mar 24; 33(3):367-74. PubMed ID: 10069670
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M, Fujimori A, Takanashi M, Kusayama T, Tokioka T, Satoh Y, Okazaki T, Uchida W, Inagaki O, Yanagisawa I.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):167-73. PubMed ID: 9369370
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacology of LR-B/057, a novel orally active AT1 receptor antagonist.
    Renzetti AR, Cucchi P, Guelfi M, Cirillo R, Salimbeni A, Subissi A, Giachetti A.
    J Cardiovasc Pharmacol; 1995 Mar 24; 25(3):354-60. PubMed ID: 7769798
    [Abstract] [Full Text] [Related]

  • 17. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O, Kushida H, Kunihara M.
    J Cardiovasc Pharmacol; 1995 Jun 24; 25(6):880-7. PubMed ID: 7564332
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
    Hilditch A, Hunt AA, Travers A, Polley J, Drew GM, Middlemiss D, Judd DB, Ross BC, Robertson MJ.
    J Pharmacol Exp Ther; 1995 Feb 24; 272(2):750-7. PubMed ID: 7853190
    [Abstract] [Full Text] [Related]

  • 20. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
    Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K, Itoh K, Kubo K, Kohara Y, Naka T.
    J Pharmacol Exp Ther; 1994 Mar 24; 268(3):1540-7. PubMed ID: 8138966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.